Last Page Update: 10.06.23 at 3:20 p.m. ET
January 30, 2020
Globally, in year four of the Pandemic, COVID-19 deaths have far exceeded 6 million (and much higher according to WHO). The public health emergency has officially ended in the U.S. and WHO has declared the global emergency over. COVID may seem done for many, but COVID is not done with us yet, no matter how badly we want it gone. COVID us still sickening and killing people. As new variants/subvariants appear, vaccines work to limit the worst of COVID, especially for the most vulnerable. Even if you are fully vaccinated (including boosters), remain vigilant. When in doubt, mask up. And get the shot if you have not. (source: JHU)
We have focused on frontline health workers. More than 180,000 (est. from W.H.O.) have died and probably many more in the Global Pandemic, and burnout among health workers raises longer-term concerns. Keeping them healthy, even after the ending of the Pandemic, is critical so they can continue to do life-saving work for low-income patients in need of essential health services and ongoing care. Many live in and serve communities that are vulnerable to a daily and deadly inequality, especially in access to health care. We have provided mental health support for health workers pushed to and beyond their limits. Health worker burnout threatens already over-burdened health systems, including the U.S. We all can help health workers who put their lives on the line to keep us safe by getting vaccinated. Caring for health begins with caring for each other.
The COVID-19 outbreak, first reported in Wuhan China in December 2019 exploded into a Global Pandemic within weeks. After three years of the Pandemic, as many put aside preventive measures, vaccines have saved many lives. The science keeps learning more, but at the same time, so does the virus. Stay informed. Stay vigilant. Scroll down, get the facts and learn more.
In year four of COVID-19, with the U.S. officially ending the public health emergency, and WHO declaring the global emergency over, COVID-19 has not gone away. New varients arise. It is still a significant risk for older adults as they represent 90% of the deaths from COVID in 2023. More than 1.17 million people have died in the U.S.. many more millions around the world and people continue to die from COVID-19 each week. The losses are almost incalculable and sadly, many could have been avoided. One thing we have learned is the value and importance of good information that we can trust. Misinformation is deadly. The rise of vaccine hesitancy is one alarming result of misinformation. It may have deadly consequences, especially for children.
All that information can be daunting. This page has offered a reliable way to access verifiable current and historical facts about COVID-19. Knowledge and trust are two of the most powerful tools in fighting this Pandemic and, indeed others that will follow. Lots of information appears online, but please confirm the reliability of the sources, particularly information shared on social media. You check the weather forecast regularly, forecasts that can change quickly as new information becomes available, and it is worth your time to check in on the latest pandemic reports as well. We have learned much in this time of COVID-19 and some of the learning is important as in this story reviewing our response to the Pandemic over three years.
We update this page as new information becomes available.
Suspension of emergency declarations, pandemic precautions and ongoing misinformation says that COVID-19 is over. The World Health Organization (WHO), however, in spite of declaring the global emergency over, warned that several factors, combined with the more transmissible subvariants continue to drive COVID-19 cases in some states and countries. Just this month, COVID hospitalizations have risen again.
The U.S. Government has officially declared the Federal COVID-19 public health emergency over. When the public health emergency expired on May 11, the White House ended most federal COVID-19 vaccine requirements. Federal employees, federal contractors, and international air travelers into the U.S. no longer need to show proof of vaccination. Other agencies also started to end their COVID-19 vaccination requirements for Head Start teachers, CMS-certified healthcare facilities, and certain non-citizens at the land border. READ MORE about the official end of emergency and the continuing threat…
Even with the official end of the emergency, the risk continues to be high, however, for the most vulnerable such as the elderly, pregnant women and people with underlying conditions (diabetes, heart disease, immunocompromised, etc.). The risk is not shared equally.
COVID is not over, nor is the toll it has taken on children and families in marginalized communities, warns a National Academies report focused on Black, Latino, and Native American families and low-income families. These numbers paint a disturbing reality:
–Nationwide, more than 200,000 children have lost a parent or caregiver to Covid and 65% of children who lost a parent or primary caregiver to Covid-19 are from Black, Latino, or Native American families.
–Relative maternal mortality rates increased by 33%, with the largest increases for Black and Latina women
“Across almost every outcome, low-income and racially and ethnically minoritized children and their families have borne the brunt of the pandemic’s negative effects, and without urgent, thoughtful interventions for their health and well-being, they will continue to bear it,” the report says.
The end of the emergency also means the end of some support programs. For most people with private or public insurance, vaccines will continue to be free. Some states gave short-term Medicaid coverage for COVID-19 vaccines, tests, and treatment to the uninsured. This coverage is likely to end for some people. The uninsured will likely have less access to COVID-19 vaccines, tests, or treatments.
Although more than 81% of the total U.S. population has received at least the first dose of vaccine, the rate of vaccine hesitancy in some areas has hampered prevention efforts, particularly in the number of people receiving at least one booster.
Vaccines offer the most hopeful view of the Pandemic. And the booster shot is even more important with the spread of the new subvariants. Updated vaccines now provide an effective booster.
Nearly 20 million lives were saved by COVID-19 vaccines during their first year of implementation, according to a new study. The researchers concluded that 600,000 more deaths could have been prevented if international immunization targets of 40% had been met by the end of 2021. The data spanned 185 countries and territories. READ MORE about the vaccine success.
“From the start of the US vaccination campaign through the end of November 2021, Covid-19 vaccines prevented about 1.1 million deaths and 10.3 million hospitalizations in the United States, according to estimates by the health care foundation The Commonwealth Fund.” Read more about lives saved in this Vox report.
Of those who are fully vaccinated with primary series (currently 69% of the U.S. population) – only 17% of eligible population are vaccinated with the up-to-date booster.
In addition, the Royal Health Society has just published a report showing the effectiveness of prevention measures during the Pandemic – data proving that they work.
World deaths from COVID have reached nearly 7 million (with experts including W.H.O estimating a much higher toll). Resistance to vaccine continues to challenge progress in finally defeating this highly contagious virus. Nearly 15 million more people died during the first two years of the Pandemic than has been reported, the W.H.O. found. READ MORE about this report on the COVID death toll in this CNN story.
Compounding the catastrophic death toll, globally, more than 10.5 million children have lost one or both of their parents during the coronavirus pandemic, nearly double the previous estimates, according to a research letter published in JAMA Pediatrics. Southeast Asia and Africa suffered the greatest rate of losses, with one out of every 50 children affected. In the Americas, this number dropped to one out of 150 children. Children in countries with lower vaccination rates and higher numbers of children per mother were more likely to be affected. READ MORE about the loss of parents.
Another alarming result of 3 years of COVID-19 can be seen in the fact that the largest sustained decline in childhood vaccinations in approximately 30 years has been recorded in official data published by WHO and UNICEF. READ MORE about this threat to children.
The United States has consistently had among the highest COVID-19 mortality rates in the world, ranking among the top twenty-five countries globally where COVID was deadliest in 2020, 2021, and 2022.
The U.S. still reports new infections and deaths in the CDC COVID data tracker.
Overall, more than 1.16 million people in the United States have died from COVID-19 (the near equivalent of the entire population of Jacksonville, Florida or Tucson, Arizona), making COVID-19 the most deadly pandemic in American history. For a local view of infection rates in your community, visit COVID-19 Community Levels from the CDC.
Health authorities address vaccine hesitancy as a significant barrier to community immunization.
The wearing of masks and proper hand washing guard against infection for those who have not received the vaccine and mask wearing are still helpful for those who have received the vaccine as well. Prevention and getting vaccinated are both necessary to stop COVID-19. In addition, the booster shots are another important level of protection. Being “up-to-date” on vaccination matters in the struggle with this fast changing virus. To learn more about the global story of the pandemic, open the ” Trusted Resources” below.
COVID-19 has exacerbated existing ethnic inequalities in health. READ MORE in the Lancet on a new study confirming the effects of ethnic health care inequalities.
Unequal access to COVID-19 treatments threatens the global recovery. Read this account in The Conversation. Efforts are underway to make treatments available in low resource countries. Read about a project to address this treatment inequity.
As many as 1.3 million lives may have been lost due to global COVID-19 vaccine inequities. Read more about the deadly effects of the unequal distribution of vaccine.
The pandemic has proven especially lethal in predominantly Black and other neighborhoods of color that face systemic inequality including lack of access to quality health care combined with a shrinking safety net for critical public services. According to the COVID Racial Data Tracker, COVID has had a deadly impact on Black, Indigenous, Latinx and other people of color with Black people dying at twice the rate of white people. Authorities also saw significant disparities in vaccination rates from zip code to zip code within communities, often reflecting economic and social inequities in those same populations. In both rich and poor countries, the virus exposes and exploits every weak point in the health infrastructure. Where you live may determine whether you live or die. Fortunately the disparity in black and neighborhoods of color in the U.S. for the COVID response has diminished due to significant health system efforts to address the issue, but many of the basic causes of health inequity remain.
Global health inequity retains its deadly potential in communities of color with poor health care access as vaccine distribution lagged dangerously behind better-resourced neighbors. As an example, 80% of people in high-income countries have been vaccinated, but just 16% of people in low-income countries are. Vaccine hesitancy is also playing a significant role in countries and in communities in the U.S. where in the past the public health system has failed the people, leading to a historic mistrust of authorities. This lack of trust also highlights the importance of robust information and public education campaigns to promote vaccination. The COVID-19 Pandemic has brought new attention to the health equity crisis on a national and global scale and the complexity of building solutions.
CDC allows some people to get a second dose of the bivalent COVID-19 vaccine
Adults who have a very weak immune system or are 65 years old or older can now get a second bivalent vaccine dose. People over the age of 65 who have already gotten a bivalent dose can get a second dose at least four months after their first dose. Certain people with very weak immune systems can also get one or more bivalent boosters at least two months after they got their first bivalent dose. They should talk to their healthcare provider to see how many vaccine doses they might need.READ MORE about the second booster…
A new study found that adults who haven’t gotten a bivalent dose of the COVID-19 vaccine have little protection from hospitalization compared to unvaccinated people. The bivalent vaccine is 62% effective at preventing hospitalization for up to 3 months, but its effectiveness drops to 24% after 6 months. The updated vaccine offers longer protection from severe illness and death though, with 69% effectiveness at 3 months and 50% effectiveness at 6 months. READ MORE about the bivalent vaccine…
FDA experts vote to make all COVID-19 vaccines and booster shots bivalent
A panel of experts that advise the FDA on its vaccine decisions voted to update all COVID-19 vaccines so that they contain the same ingredients as the two-strain shots that are now used as booster doses. The vote means that young children and others who haven’t gotten a vaccine may soon be able to receive two-strain vaccines that more closely match the variants in the U.S. READ MORE about bivalent vaccines and boosters.
COVID-19 vaccine added to immunization schedules for adults and children
COVID-19 vaccines are now part of the routine shots recommended by the CDC for kids, teens, and adults. The vaccine schedule represents the current guidelines for how to protect people against common diseases. It does not mean the CDC is requiring any person to get a COVID-19 vaccine. These guidelines suggest that all people 6 months old and older should get their COVID-19 vaccines and a booster shot when they can. READ MORE about the CDC vaccination schedule.
Misinformation has hindered vaccine uptake among pregnant women. A recent poll found that one in seven adults (14%) have heard that pregnant women should not get the COVID-19 vaccine and believe it to be true, rising to nearly one in four (24%) among women who are pregnant or planning to become pregnant. READ MORE about this lingering misinformation.
COVID-19 caused a large increase in pregnancy-related deaths in the U.S. The death rate of mothers after childbirth in the U.S. is higher than many other high-income countries. Black women had a higher maternal death rate than White and Hispanic or Latina women. READ MORE about new study.
COVID-19 vaccines reduce the risk of post-COVID-19 heart attacks and strokes
In the largest study to date, experts found that the risk of heart attack or stroke after catching COVID-19 was reduced by 41% in people who got at least two doses of a COVID-19 vaccine. Even people with at least one shot got some defense, reducing the risk of a major heart event by about 24%. This study suggests that COVID-19 vaccines may help protect against some post-COVID-19 health problems. READ MORE about reducing heart attack and stroke risk...
Urging Vaccinations for Children
COVID-19 is the 8th most common cause of death among children in the U.S. A recent study found that COVID-19 was a leading cause of death for children 0-19 years old. Between August 2021 and July2022, 821 children died from the virus at a rate of 1 per 100, 000. COVID-19 ranked fifth in disease-related deaths and first in infectious or respiratory illness deaths, causing more deaths than the flu and pneumonia. While it’s rare for kids and teens to die in the U.S., COVID-19 is now the leading cause of death from infectious disease for this age group. READ MORE about COVID threat to children.
More than 40% of parents who have children 6 months to 4 years old say that they will “definitely not” get their child vaccinated against COVID-19. Only 7% of parents have gotten their kids in this age group at least one dose of a COVID-19 vaccine. Scientists and medical experts have worked hard to ensure the vaccine is safe for these young kids. The COVID-19 virus, on the other hand, can be very dangerous to them. READ MORE about vaccine hesitancy affecting children.
The CDC recommends that all children 6 months through 5 years of age should receive a COVID-19 vaccine. This means that all Americans ages 6 months and older are now eligible for vaccination with the Pfizer-BioNTech or Moderna vaccines to better protect them from COVID-19. READ MORE about the recommendation.
Kids 5 years old and older should get their COVID-19 booster shot. These new boosters can better defend kids and adults from getting very sick from COVID-19. Kids who are 5 years old or older can get Pfizer’s new “bivalent” booster, and kids who are 6 years old or older can get Moderna’s. They should get their new booster shot at least 2 months after they get their second primary series shot or their most recent (monovalent) booster shot. READ MORE about the booster for children.
Federal Reports on Long COVID
The Department of Health and Human Services (HHS) released two new reports on Long COVID. The National Research Action Plan on Long COVID details advances in current research and charts a course for future study. The Services and Supports for Longer-Term Impacts of COVID-19 report highlights resources for health care workers, and those effected by broader effects of COVID-19, including not only Long COVID but also effects on mental health and substance use, and loss of caregivers and loved ones. READ MORE about COVID long term effects.
FDA regulators have authorized two antiviral medications to treat covid-19, one from Pfizer and a second from Merck. Both the Paxlovid pill from Pfizer and Merck’s Molnupiravir are considered useful tools in the fight against the coronavirus. In order to be effective, however, they must be given very early in an infection.
The FDA has revised the previous emergency use authorization (EUA) for Paxlovid (nirmatrelvir andritonavir) so that state-licensed pharmacists can now prescribe the drug to eligible patients. Patients seeking to determine their eligibility must bring their health records from the past year, their most recent bloodwork, and a list of all their medications to their pharmacist. Paxlovid must be taken within five days after symptoms begin. READ MORE about Paxlovid.
Reports of a rebound effect from some people who have used an antiviral medication have generated a closer look at the specifics of its use, according to a story from NPR. READ MORE about the rebound effect.
Disclaimer: This project was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention grant number 1 NU50CK000588-01-00. The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this resource center do not necessarily represent the policy of CDC or HHS and should not be considered an endorsement by the Federal Government.
Information you can trust
Americares continues to combat the spread of disinformation and promote science and healthy behaviors that can help stem the spread of the virus. The first and most important response to a disease outbreak is to get good information. Get the facts, not fear. Understand the complexity of assembling data from a vast variety of global sources and consider using more than one source (and make sure it is a trusted source) to get a broader picture of what is happening day to day in the Pandemic.
To find answers to more of your questions about vaccines visit the WHO vaccine tracker.
To track information on the various vaccines being developed for COVID-19 visit the New York Times vaccine tracker.
COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. The JHU dashboard has ceased providing updates as of 3/10/23. Visit this resource for historical information only.
Another important daily data source can be found at CDC COVID data tracker.
The “homemade” aggregator website put together by a single enterprising programmer has become a valued, accessible data source. It continues to be updated.
The COVID Racial Data Tracker is a collaboration between the COVID Tracking Project and the Antiracist Research & Policy Center. Click here for the most complete race and ethnicity data on COVID-19 in the United States.
Researchers and Public Health Experts unite to bring clarity to key metrics guiding coronavirus response. This is a new resource about COVID risk levels in different locations to help guide personal decision-making. Click here to access this new information.
NPR: Tracking the global spread of the outbreak – follow this regularly updated map and timeline.
Washington Post: How Do We Build Herd Immunity? Click here to learn how it happens>
A Global Crisis
The coronavirus outbreak that was first reported in December 2019 in Wuhan China exploded into a Global Pandemic – spreading like flood waters finding any and every opening to infect and kill.
According to an NPR virus tracker COVID-19, the official name of the disease caused by the virus (SARS-CoV-2) registered its first confirmed cases outside China on Jan. 20, in Japan, Thailand and South Korea. On Jan. 21, the first case in the U.S. was identified in Washington state. On Jan. 24, the first two European cases were confirmed in France. By Feb. 1, eight European nations had confirmed cases of COVID-19, and a month later that count had risen to 24 countries with at least 2,200 cases, most of them in Italy. On March 11 as Italy surpassed 10,000 cases, China, the original epicenter, reported a drop in cases of infection. March also saw a rapid spread of the virus throughout the U.S., with all 50 states reporting cases by March 17. The world took three months to reach the mark of 100,000 reported infections. The second 100,000 were added in just 12 days.
The danger to health systems is a central concern, particularly the vulnerability of health workers; thousands of health workers have been infected and many have died as health facilities became overwhelmed by the numbers of patients. Of the more that 180,000 health worker deaths that have been officially recorded, the largest number have occurred in Mexico and the U.S. (more than 3,600 in the U.S.). A lack of consistent data on health workers has hampered efforts to report on the exact toll COVID-19 is having on health workers globally and in the U.S.
Of the 192 countries/regions infected, the U.S. faced the largest outbreak. Spain and Italy in the early stages of the pandemic had a much higher death rate, reflecting an aging population – the virus is most deadly to the elderly and those with underlying health issues. Countries taking an early systematic approach to stemming the outbreak saw a leveling off and decline in reported cases, highlighting the impact of prevention and protection programs while other countries such as Brazil and Russia that had been slower to respond continued to see the infection rate accelerate. Italy and Spain shut down as the outbreak intensified and other countries closed their borders, steps that slowed the spread and offered a cautious path toward reopening. Countries such as New Zealand, Vietnam and Senegal set a standard for controlling the outbreak early by quickly establishing and following strict disease control protocols.
Impact on Vulnerable Communities
Soon after one of the first U.S. cases was reported in Washington State on January 21, another significant outbreak followed in Westchester County NY where a “containment zone” was established – a hot spot that began with one infected person. The swift decision to implement more stringent measures, including closing businesses and all but essential services, self-quarantines, masks, testing, tracing, social distancing and strong shelter-in-place recommendations in both Washington State and the Westchester communities slowed the rate of infection in those early outbreaks.
New York City soon became the major national hot zone and New York state the epicenter of the outbreak with more reported infections than any country. As the rate of infection and death toll increased in the U.S., many states including California, New York, Illinois, Ohio and Louisiana issued the “shelter-in- place” order. Communities throughout the country restricted all gatherings and encouraged people to limit social interaction and stay home to slow the progression of the pandemic. States and cities cancelled major events, conferences and other large gatherings while closing all businesses deemed non-essential and banning most events.
Decisions by some state and local leaders to keep strong measures in place to contain the virus for an extended period led to a leveling off and a significant decline in the infection and death rates in a handful of states. New York state implemented a phased reopening in regions that achieved certain benchmarks of lowered infection and fatality rates, while at the same time new hot spots emerge in many states as the pandemic continues its deadly spread. The new outbreaks led to travel restrictions into states that achieved a sharp decline in infection and death rates.
One of the most disturbing aspects of the pandemic is its disproportionate impact on predominantly Black, Indigenous and Latinx neighborhoods where social and economic inequality, a greater incidence of underlying health conditions and lack of access to health care have contributed to an alarming disparity in infection rates and deaths. The continued nationwide protests against systemic racism have given the entire issue a major role in the pandemic narrative.
Medical experts had cautioned that a premature reopening and lack of government mandates could lead to a resurgence of infections which happened in some states. The disease has been relentless, striking government leaders, top athletes and celebrities right along with health and other essential workers on the front lines of the service economy. The death of more than 3,600 health workers in the U.S., brutally underlined the critical importance of adequate supplies of protective equipment and infection prevention supplies, as well as training in their use.
What are we doing?
Americares goal is to save lives and stop the spread of COVID-19.
Throughout the pandemic, Americares has focused our support on frontline health workers and the people they serve,
especially low-income, uninsured people in the United States and around the world.
Americares has provided access to critical supplies, support for ongoing health services and access to credible information.
The Latest COVID Initiative: COVID Treatment Quick Start
The COVID Treatment Quick Start Consortium will support governments to introduce and scale up access to new and effective COVID-19 oral antiviral therapies in high-risk populations. The Consortium brings together Duke University, the Clinton Health Access Initiative (CHAI), COVID Collaborative, and Americares as implementing partners, with support from the Open Society Foundations, Pfizer and the Conrad N. Hilton Foundation. Partner countries include Ghana, Kenya, Laos, Malawi, Nigeria, Rwanda, South Africa, Uganda, Zambia, and Zimbabwe.
The project will kick-start programs through a donation by Pfizer of 100,000 courses of PAXLOVID™ (nirmatrelvir/ritonavir), for which the World Health Organization (WHO) has issued a strong recommendation for use in high-risk individuals with mild to moderate COVID-19, administered within five days of symptom onset. Partners involved in the COVID Treatment Quick Start Consortium are committed to ensuring a more equitable scale-up of test-and-treat programs with antiviral medicines in low- and middle-income countries, to help address some of the challenges faced in the global scale up of vaccines.
Over the past three years, the COVID-19 pandemic has exposed significant global inequities in access to therapeutics, vaccines, testing, and other medical interventions that could limit the range and impact of the disease. Access to treatment has become an urgent need to tackle alongside persistently low primary vaccination and booster rates in many countries. New antiviral medicines such as PAXLOVID and molnupiravir have been available in high-income countries since late 2021 but are not yet widely available in low- and middle-income countries. In addition, scale-up of self-testing for COVID-19 in these settings will enable even more effective approaches.
Over the next 18 months, the Quick Start Consortium will catalyze implementation of test-and-treat programs and operational research in partner countries to pave the way for quality assured, low-cost generic equivalent drugs. Read more about the Consortium Project.
Americares continues to deliver protective supplies – masks, gowns, gloves and disinfectants. Our global distribution network has provided more than 18 million units of protective equipment and infection-prevention supplies for health workers worldwide. Americares has provided support to 993 partner organizations in 46 countries. The supplies helped protect health workers and patients from infection and ensure facilities could stay open and provide essential health services that low-income communities depend on. For some, Americares deliveries were their only source of items like gloves and masks; for others, the donations were critical budget relief during a time of instability.
In the U.S. alone, Americares delivered hundreds of tons of protective supplies to health facilities in 50 states, the District of Columbia, Puerto Rico, U.S. Virgin Islands and Northern Mariana Islands. Our support included 35 tons of personal protective equipment, infection-control supplies and hygiene products for Native American communities devastated by the COVID-19 pandemic. Read more about the shipments of critically needed supplies to the Hopi Tribe and Navajo Nation.
International and domestic shipments continue.
Americares global network of health care partners depends on the continuity of regular shipments of medicine and supplies from our distribution center. The most vulnerable in these communities have no other access to care.
With the pandemic in its fourth year, Americares continues to address the health care gaps that most affect disadvantaged communities. This has included continuity of quality health services and access to essential medicine and supplies. This work becomes more complex and even more important as we respond to manmade and climate change related disasters such as the conflict in Ukraine and extreme weather events in the U.S. and around the world.
Watch the video of our Distribution Center in action!
Americares has worked on the frontlines of the COVID-19 response in the US where we have been needed. For example, In response to an urgent request from FEMA, Americares mobilized three medical professionals to support Citizen Potawatomi Nation (CPN) Health Services’ COVID-19 response. CPN Health Services is located in Oklahoma and services patients who are either Native American, have a Certificate of Degree of Indian Blood (CBID), or are a CPN service provider. Americares three medical professionals helped to administer COVID-19 vaccinations, COVID-19 booster shots to eligible populations, COVID-19 testing, and flu vaccinations. The two health clinics operated by CPN Health Services (East and West) provide health care services, including COVID-19 vaccination and testing, to Native populations including but not limited to Potawatomi, Cherokee Nation, Chickasaw Nation and the Kickapoo Tribe of Oklahoma.
Americares response team of medical professionals provided daily assistance, allowing tribal leadership and FEMA to identify a longer term staffing plan.
Americares provided primary care services at its clinics in Connecticut, Colombia, El Salvador and its mobile health centers in India throughout the pandemic. In the Americares clinics health workers helped to identify suspected COVID-19 infections and referred patients for testing and related treatment. In our El Salvador clinic location, we provided rapid antigen testing.
The COVID-19 pandemic increased the barriers to care that low-income uninsured people experience every day. With clinics closed or on reduced hours early in the Pandemic, patients who already struggled to access care risked complications and even death from untreated chronic diseases and other health problems. Americares COVID-19 response helped ensure that patients at both Americares-own clinics and those of our partners had safe access to health services.
In Colombia, India and the United States, Americares clinics quickly pivoted from in-person appointments to telehealth services in response to government restrictions, opening when rules allowed. Americares clinics in Colombia, and El Salvador closed temporarily and then were able to restore in-person care, adhering to strict safety protocols for staff and patients. In response to the devastating COVID-19 surge in India, Americares India, which normally operated seven mobile health centers in the slum communities of Mumbai, faced an extraordinary surge in the Pandemic across the country in 2021 and expanded its support for hospitals overwhelmed by the surge. Americares India team supported 242 dedicated COVID-19 treatment facilities in 32 states and union territories with life-saving medical equipment and desperately needed personal protective equipment. Learn more about the Americares India response.
Overall, more than one million patient visits, including telehealth, have been managed in Colombia, El Salvador, India, Peru and the U.S. (Connecticut) since the start of the Pandemic.
Our top concern has been the capacity of under-resourced health centers to respond to the pandemic. Americares has trained health workers in infection prevention and control, disaster preparedness and mental health and psychosocial support. Americares hosted 718 training sessions attended by nearly 46,000 participants. Americares has trained more than 26,000 participants in psychological first aid and coping skills to handle fear, stress and anxiety.
To reinforce vaccine confidence among health care personnel, and in turn the patients and communities they serve, Americares is supporting and will continue to promote a range of efforts to build COVID-19 vaccine confidence among our health center networks and the broader public. Vaccine confidence training and education sessions continue to be provided to health workers and key stakeholders across Africa and the Middle East, Latin America and the Caribbean, and the United States. The CDC Reinforcing COVID-19 Vaccine Confidence project was launched to build and reinforce COVID-19 vaccine confidence among healthcare personnel in the safety net sector in the U.S. and in turn the patients they serve. In addition, the “Wear A Mask” campaign generated more than 2 million engagements on Social Media and 42,000 streams of the Wear A Mask song.
Other ongoing work includes:
— Grant support to partners who have implemented COVID response, prevention or misinformation work, such as Birat Medical Trust in Nepal for purchase of PPE, hygiene supplies and surge support lab personnel and support to Misean Cara supporting multiple partners in Africa on various COVID projects.
— Support for vaccination efforts: COVID vaccination in the Philippines; COVID vaccinate-with-confidence work in the US including ECHO sessions for free and charitable clinic staff; COVID vaccination awareness/uptake work in Tanzania.
Without running water, it’s nearly impossible for staff and patients to follow safety protocols so, in 10 countries, Americares collaborated with local health partners to improve water infrastructure. We have provided communities with hundreds of water infrastructure improvements, including hand-washing and hand-sanitizing stations. In every location where Americares has provided hand-washing stations, we have also done community education and outreach on hygiene. We continue to support WASH interventions with emphasis on health workers providing quality of care.
In Peru, Americares provided surge medical support in Peru from June 2020 through March 2021 to support health facilities overwhelmed by the pandemic. Americares relief workers also provided rapid COVID-19 testing in partnership with VIDA Peru, at mobile clinics in communities with high rates of COVID-19 in Lambayeque, Lima and Piura and reached over 200,000 people with COVID-19 health education throughout the duration of the project. Additionally, Americares psychologists provided mental health consultations.
Americares knows from a long history of disaster response that maintaining primary care services during crisis is critical to saving lives and restoring health.
Watch the video with Nurse Practitioner Mary Beth Fessler on treating patients at Americares Free Clinics during the pandemic.
Americares offers this useful resource for health workers and our health center partners around the country who serve the most vulnerable during the COVID-19 pandemic. Visit our clinic resource page.
Americares thanks you
Thank you to the following institutional partners for their support of Americares COVID-19 response:
Americares Emergency Response Partners
What can you do?
We work with a dedicated and experienced staff, a global network of health care partners, corporate partners and donors. The success of this unprecedented fight against a global pandemic, even after three years, relied on the coordinated efforts of federal, state and local authorities, global and local non-profits, community action and most of all you.
You have the greatest power to change the course of this global disaster: Get the vaccine (and a booster). It will help to keep you, your family and your community safe. Even with mandates ending, the pandemic is still with us. Be cautious and stay healthy.
And you can do one other important thing: Fight the “infodemic” by getting the facts, sharing the facts and following the science.
Prevention and protection come down to individual actions to keep everyone safer. Those actions are the key to controlling the pandemic. Remember to be vigilant. In spite of the progress in more than three years, we still have a long way to go before most people around the world receive the required doses. Treatments for COVID have been approved but none offer a cure. The virus is not going away. In fact, it has returned in waves along with new variants of the virus. It remains highly contagious, and it seizes any opportunity. Don’t give it one. Get the vaccine and booster.
Download a useful guide on proper hand washing and other preventive tips right now. It might be a lifesaver.
Haga clic aquí por un guía de lavado de manos—podría salvar su vida. Hag clic aquí.
“Because public health measures are really only as good as the public using them and implementing them, or at least the majority. I’d say that especially with this outbreak, this is something that we’re all in on together. It’s not just about my risk or my family’s risk, you know, and that kind of individual piece, this is something where we’re working as a community.”
Dr. Julie Varughese
“Because public health measures are really only as good as the public using them and implementing them, or at least the majority. I’d say that especially with this outbreak, this is something that we’re all in on together. It’s not just about my risk or my family’s risk, you know, and that kind of individual piece, this is something where we’re working as a community.”
A third of Americans report signs of clinical anxiety or depression in a US Census Bureau poll, documenting COVID-19’s alarming impact on mental health.
Watch mental health experts discuss and share mental health issues that arise during a crisis along with tips from Mental Health professional Lisa LaDue about relieving stress in difficult times. vimeo.com/showcase/mentalhealthindisasters
Americares has extensive experience with outbreaks including in response to Ebola in West Africa and DRC, Zika in Latin America and the Caribbean as well as recent outbreaks of Measles and Dengue so we are ready to respond as the situation evolves. The organization has professional relief workers ready to respond to disasters at a moment’s notice and stocks emergency medicine and supplies in warehouses in the United States, Europe and India that can be delivered quickly in times of crisis.